Price
797.6
-0.29%52W Range
Market Cap
₹5,844.30 Cr
Traded: ₹11.92 Cr (0.20%) 0.0x
Free Float: ₹1,749.20 Cr (0.68% of FF traded)
Volume · 60D trend
1.49 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +13.0% | +27.0% | +22.0% | -- | +3.0% | Decelerating |
| Profit | +19.0% | +32.0% | -14.0% | -- | -27.0% | Decelerating |
| Return | +18.0% | +37.0% | +14.0% | -25.0% | -- | Decelerating |
| ROE | +8.0% | +10.0% | +7.0% | -- | -- | Stable |
Quarterly Results
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,069 | 979 | 984 | 956 | 1,015 | 988 | 929 | 932 | 812 | 552 | 500 | 515 | 523 | 519 | 570 |
| Expenses | 952 | 902 | 920 | 858 | 893 | 884 | 859 | 857 | 728 | 489 | 453 | 454 | 453 | 456 | 504 |
| Operating Profit | 117 | 77 | 65 | 97 | 123 | 104 | 70 | 75 | 84 | 62 | 47 | 60 | 70 | 63 | 65 |
| OPM % | 11.0% | 8.0% | 7.0% | 10.0% | 12.0% | 11.0% | 7.0% | 8.0% | 10.0% | 11.0% | 9.0% | 12.0% | 13.0% | 12.0% | 11.4% |
| Other Income | 18 | 20 | 19 | 21 | 20 | 13 | 13 | 8 | 6 | 8 | 9 | 8 | 7 | 9 | 13 |
| Interest | 26 | 24 | 22 | 22 | 21 | 19 | 18 | 19 | 20 | 5 | 6 | 6 | 7 | 6 | 6 |
| Depreciation | 39 | 46 | 43 | 39 | 42 | 30 | 29 | 28 | 27 | 22 | 21 | 19 | 19 | 19 | 17 |
| Profit Before Tax | 70 | 26 | 19 | 57 | 79 | 67 | 36 | 36 | 43 | 44 | 29 | 43 | 51 | 48 | 55 |
| Tax % | 49.0% | 44.0% | 57.0% | 27.0% | 33.0% | 25.0% | 21.0% | 25.0% | -3.0% | 30.0% | 19.0% | 25.0% | 7.0% | 15.0% | 16.8% |
| Net Profit | 36 | 15 | 8 | 41 | 53 | 50 | 28 | 27 | 44 | 30 | 24 | 33 | 47 | 41 | 46 |
| Exceptional Items | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| EPS (Rs) | 4.9 | 2.0 | 1.1 | 5.7 | 7.4 | 7.0 | 3.9 | 3.8 | 7.0 | 5.0 | 3.9 | 5.4 | 7.8 | 6.7 | 7.6 |
| Sales Growth (YoY) | 5.3% | -0.9% | 5.9% | 2.6% | 25.0% | 79.0% | 85.8% | 81.0% | 55.3% | 6.4% | -12.2% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 9.2% | -0.5% | 2.9% | -5.8% | 2.7% | 6.3% | -0.3% | 14.8% | 47.1% | 10.4% | -2.9% | -1.5% | 0.8% | -8.9% | -- |
| OP Growth (YoY) | -4.9% | -26.0% | -7.1% | 29.3% | 46.4% | 67.7% | 48.9% | 25.0% | 20.0% | -1.6% | -28.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | 51.9% | 18.5% | -33.0% | -21.1% | 18.3% | 48.6% | -6.7% | -10.7% | 35.5% | 31.9% | -21.7% | -14.3% | 11.1% | -3.4% | -- |
| Profit Growth (YoY) | -32.0% | -71.0% | -71.3% | 52.6% | 19.4% | 65.5% | 18.8% | -16.5% | -6.2% | -25.0% | -42.2% | -17.4% | -22.5% | 35.0% | 43.0% |
| EPS Growth (YoY) | -33.6% | -71.7% | -72.1% | 48.4% | 5.9% | 40.2% | 0.8% | -28.9% | -10.3% | -25.1% | -48.3% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 146.7% | 80.9% | -80.6% | -23.4% | 5.1% | 78.7% | 3.1% | -45.4% | 39.2% | 28.4% | -27.2% | -31.1% | 16.3% | -11.4% | -- |
| OP Margin | 10.9% | 7.9% | 6.6% | 10.2% | 12.1% | 10.5% | 7.5% | 8.1% | 10.3% | 11.2% | 9.4% | 11.7% | 13.4% | 12.1% | 11.4% |
| Net Margin | 3.4% | 1.5% | 0.8% | 4.3% | 5.2% | 5.1% | 3.0% | 2.9% | 5.4% | 5.4% | 4.8% | 6.4% | 9.0% | 7.9% | 8.0% |
| Material Cost % | 48.7% | 45.8% | 52.1% | 46.3% | 49.8% | 46.4% | 52.0% | 51.9% | 49.3% | 44.3% | 47.1% | 49.5% | 52.7% | 51.7% | 53.0% |
| Employee Cost % | 31.1% | 35.7% | 33.1% | 33.6% | 31.1% | 33.8% | 30.8% | 31.3% | 29.8% | 35.4% | 36.1% | 31.1% | 26.1% | 29.1% | 28.0% |
| P/S | 1.47 | 1.29 | 1.19 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 58.35 | 42.94 | 30.16 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 2.70 | 2.36 | 2.17 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Transcript of Q1 FY27 earnings conference call held on August 12, 2026.
Schedule of meeting with Institutional Investors/Research Analysts.
Audio recording of Q1 FY27 results conference call.
Investor presentation on Q1 FY27 results.
Press Release on the un-audited financial results of the Company for the quarter ended June 30, 2026.
Intimation of grant of options under ESOP Scheme of the Company
Intimation of allotment of equity shares under ESOP Scheme of the Company.
Financial Results For The Quarter ended June 30, 2026
Outcome of Board meeting held on August 11, 2026
Invitation for Q1 FY27 financial results investors conference call to be held on Wednesday, August 12, 2026 at 11.30 AM IST.
Gokaldas Exports Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the un-audited financial results ....
Scrutinizer's report and voting results of the equity Shareholders meeting of the Company held on July 31, 2026, pursuant to the order of National Company Law Tribunal, Mumbai Bench.
Proceedings of the Equity Shareholders Meeting of the convened pursuant to the order of National Company Law Tribunal, Mumbai Bench dated May 11, 2026.
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Life Insurance Company Ltd
Intimation of closure of trading window
Newspaper publication.
Notice of meeting of equity shareholders of the Company to be convened pursuant to the directions of the Hon'ble National Company Law Tribunal, Mumbai Bench, on Friday, July 31, 2026.
Schedule of Institutional Investors meeting to be held with Senior Management of the Company on June 29, 2026
Schedule of Institutional Investors meeting to be held with Senior Management of the Company from June 08, 2026 to June 10, 2026.
Transcript of Q4 FY''''26 earnings conference call held on May 25, 2026.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Goldman Sachs Asset Management International & PAC
Audio recording of investors call.
Investor presentation on Q4 and FY26 results
Press Release on the audited financial results of the Company for the quarter and year ended March 31, 2026.
Financial Results For The Quarter And Year Ended March 31, 2026
Outcome of Board meeting held on May 22, 2026
Financial Results For The Quarter and year Ended March 31, 2026
Invitation for Q4 FY26 financial results investors conference call to be held on Monday, May 25, 2026 at 11.30 AM IST.
Gokaldas Exports Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve the audited financial results ....
Annual Secretarial Compliance Report for the year ended March 31, 2026
Intimation of appointment of President - International Business and resignation of Chief Operating Officer.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund
Intimation of allotment of equity shares.
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026
Intimation of appointment of Chief Operating Officer - India (Senior Management Personnel).
Intimation of closure of trading window.
Schedule of meeting with Institutional Investors/Research Analysts
Intimation of allotment of Equity shares under ESOP Scheme of the Company.
Schedule of investors call.
Schedule of meeting with Institutional Investors/Research Analysts
Intimation of change in Registered office address of the Company.
Schedule of Investors meet.
Schedule of investor meet.
Transcript of Q3 FY''26 earnings conference call held on February 02, 2026.
Audio recording of investors call.
Investor presentation on Q3 FY26 results.
Outcome of Board meeting held on January 31, 2026
Financial results for the quarter ended December 31, 2025
Press Release on the Q3 FY26 results.
Annual Reports
15Credit Ratings
6Concalls
25Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Jun 2024
30 Jun 2024Feb 2024
29 Feb 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Sep 2023
30 Sept 2023Aug 2023
31 Aug 2023Jun 2023
30 Jun 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Oct 2022
31 Oct 2022Jul 2022
31 Jul 2022Jan 2022
31 Jan 2022Oct 2021
31 Oct 2021Aug 2021
31 Aug 2021May 2021
31 May 2021Jan 2021
31 Jan 2021May 2019
31 May 2019Held by ETFs
1 ETFs hold gokex · sorted by weight
Held by Mutual Funds
45 schemes hold gokex · sorted by weight